A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein.

A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein.
复制标题

人单链 Fv 胞内抗体可阻断过度表达 α-突触核蛋白的异常细胞效应。

DOI:
10.1016/j.ymthe.2004.08.019
复制
发表时间:
2004
期刊:
Molecular therapy : the journal of the American Society of Gene Therapy.
影响因子:
--
通讯作者:
Messer,Anne
Messer,Anne
中科院分区:
--
文献类型:
--
作者:
Zhou,Chun;Emadi,Sharareh;Sierks,MichaelR;Messer,Anne

文献摘要

相似文献

α-Synuclein (α-syn) has been identified as the major component of Lewy bodies that characterize neurodegenerative synucleinopathies, including Parkinson's disease. Overexpression of α-syn, and prefibrillar α-syn oligomers, has been implicated in these pathologies; therefore, prevention of prefibril accumulation, and inhibition of other aberrant effects of overexpressed α-syn, could provide novel treatments. Here, we have selected a human single-chan Fv (scFv) antibody, D10, that binds human monomeric wild-type α-syn. We demonstrate, by retargeting assays and coimmunoprecipitation, that the D10 scFv is a specific and efficient intracellular antibody (intrabody). By transfecting the D10 scFv gene into an HEK 293 cell line that overexpresses wild-type α-syn, we show that the D10 intrabody stabilizes detergent-soluble monomeric α-syn and inhibits the formation of detergent-insoluble high-molecular-weight α-syn species. In addition, the D10 intrabody ameliorates the decreased cell adhesion that characterizes the α-syn-overexpressing cells. Given the important role of α-syn pathology, and the facility with which intrabodies can be further engineeredin vitro,anti-α-syn intrabodies may represent novel molecular therapeutics for synucleinopathies, with implications for other neurodegenerative disorders caused by misfolded accumulated proteins.